BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 23090251)

  • 1. Nasopharyngeal carcinoma: correlation of apparent diffusion coefficient value with prognostic parameters.
    Abdel Razek AA; Kamal E
    Radiol Med; 2013 Jun; 118(4):534-9. PubMed ID: 23090251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prognostic value of pretreatment tumor apparent diffusion coefficient values in nasopharyngeal carcinoma.
    Yan DF; Zhang WB; Ke SB; Zhao F; Yan SX; Wang QD; Teng LS
    BMC Cancer; 2017 Oct; 17(1):678. PubMed ID: 29020937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diffusion-weighted magnetic resonance imaging for early response assessment of chemoradiotherapy in patients with nasopharyngeal carcinoma.
    Chen Y; Liu X; Zheng D; Xu L; Hong L; Xu Y; Pan J
    Magn Reson Imaging; 2014 Jul; 32(6):630-7. PubMed ID: 24703576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Invasive ductal carcinoma: correlation of apparent diffusion coefficient value with pathological prognostic factors.
    Razek AA; Gaballa G; Denewer A; Nada N
    NMR Biomed; 2010 Jul; 23(6):619-23. PubMed ID: 20232453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Malignant cervical lymphadenopathy: diagnostic accuracy of diffusion-weighted MR imaging.
    King AD; Ahuja AT; Yeung DK; Fong DK; Lee YY; Lei KI; Tse GM
    Radiology; 2007 Dec; 245(3):806-13. PubMed ID: 17911539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The diagnostic value of 1.5-T diffusion-weighted MR imaging in detecting 5 to 10 mm metastatic cervical lymph nodes of nasopharyngeal carcinoma.
    Jin GQ; Yang J; Liu LD; Su DK; Wang DP; Zhao SF; Liao ZL
    Medicine (Baltimore); 2016 Aug; 95(32):e4286. PubMed ID: 27512841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of diffusion-weighted imaging in the discrimination of benign and metastatic parotid area lymph nodes in patients with nasopharyngeal carcinoma.
    Chen C; Lin Z; Xiao Y; Bai P; Yue Q; Chen Y; Chen L
    Sci Rep; 2018 Jan; 8(1):281. PubMed ID: 29321485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diffusion-weighted imaging to differentiate metastatic from non-metastatic retropharyngeal lymph nodes in nasopharyngeal carcinoma.
    Li H; Liu XW; Geng ZJ; Wang DL; Xie CM
    Dentomaxillofac Radiol; 2015; 44(3):20140126. PubMed ID: 25430557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diffusion weighted magnetic resonance imaging of pre and post treatment nasopharyngeal carcinoma.
    Hirshoren N; Damti S; Weinberger J; Meirovitz A; Sosna J; Eliashar R; Eliahou R
    Surg Oncol; 2019 Sep; 30():122-125. PubMed ID: 31500774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Preliminary application of diffusion-weighted imaging with 3.0 T magnetic resonance scanner for nasopharyngeal carcinoma].
    Liu K; Ouyang H; Zhou CW; Tao H
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2010 Apr; 32(2):200-4. PubMed ID: 20450553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Characteristics of high resolution diffusion weighted imaging apparent diffusion coefficient histogram and its correlations with cancer stages in patients with nasopharyngeal carcinoma].
    Wang GJ; Wang Y; Ye Y; Chen F; Lu YT; Li SL
    Zhonghua Yi Xue Za Zhi; 2017 Nov; 97(41):3244-3249. PubMed ID: 29141363
    [No Abstract]   [Full Text] [Related]  

  • 12. Apparent diffusion coefficient for discriminating metastatic lymph nodes in patients with squamous cell carcinoma of the head and neck.
    Pekçevik Y; Çukurova İ; Arslan İB
    Diagn Interv Radiol; 2015; 21(5):397-402. PubMed ID: 26200481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiation between nasopharyngeal carcinoma and lymphoma at the primary site using whole-tumor histogram analysis of apparent diffusion coefficient maps.
    Lian S; Zhang C; Chi J; Huang Y; Shi F; Xie C
    Radiol Med; 2020 Jul; 125(7):647-653. PubMed ID: 32072391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic accuracy of diffusion-weighted MR imaging for nasopharyngeal carcinoma, head and neck lymphoma and squamous cell carcinoma at the primary site.
    Fong D; Bhatia KS; Yeung D; King AD
    Oral Oncol; 2010 Aug; 46(8):603-6. PubMed ID: 20619723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of apparent diffusion coefficient value with prognostic parameters of endometrioid carcinoma.
    Inoue C; Fujii S; Kaneda S; Fukunaga T; Kaminou T; Kigawa J; Harada T; Ogawa T
    J Magn Reson Imaging; 2015 Jan; 41(1):213-9. PubMed ID: 24339027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of Choline/Creatine and Apparent Diffusion Coefficient values with the prognostic parameters of Head and Neck Squamous Cell Carcinoma.
    Razek AA; Nada N
    NMR Biomed; 2016 Apr; 29(4):483-9. PubMed ID: 26867020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinguishing early-stage nasopharyngeal carcinoma from benign hyperplasia using intravoxel incoherent motion diffusion-weighted MRI.
    Ai QY; King AD; Chan JSM; Chen W; Chan KCA; Woo JKS; Zee BCY; Chan ATC; Poon DMC; Ma BBY; Hui EP; Ahuja AT; Vlantis AC; Yuan J
    Eur Radiol; 2019 Oct; 29(10):5627-5634. PubMed ID: 30903340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of the primary lesion apparent diffusion coefficient (ADC) in nasopharyngeal carcinoma: a retrospective study of 541 cases.
    Zhang Y; Liu X; Zhang Y; Li WF; Chen L; Mao YP; Shen JX; Zhang F; Peng H; Liu Q; Sun Y; Ma J
    Sci Rep; 2015 Jul; 5():12242. PubMed ID: 26184509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of diffusion-weighted imaging and arterial spin labeling at 3.0 T for the clinical staging of nasopharyngeal carcinoma.
    Xiao B; Wang P; Zhao Y; Liu Y; Ye Z
    Clin Imaging; 2020 Oct; 66():127-132. PubMed ID: 32480267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The primary lesion apparent diffusion coefficient is a prognostic factor for locoregionally advanced nasopharyngeal carcinoma: a retrospective study.
    Huang TX; Lu N; Lian SS; Li H; Yin SH; Geng ZJ; Xie CM
    BMC Cancer; 2019 May; 19(1):470. PubMed ID: 31101029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.